Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75
- PMID: 2094597
- PMCID: PMC2393030
Immunity to falciparum and vivax malaria induced by irradiated sporozoites: a review of the University of Maryland studies, 1971-75
Abstract
The immunogenicity in adult male volunteers of sporozoites of Plasmodium falciparum and P. vivax was evaluated at the University of Maryland from 1971 to 1975. Inoculation of large numbers of sporozoites by mosquitos that had been X-irradiated proved safe and well tolerated, and the sporozoites were rendered noninfective. Three volunteers were protectively immunized by this method, one against P. falciparum, one against P. vivax, and one against both species. Protection was species- and stage-specific, but effective against all strains tested within a species, and was reflected by a rise in titre of antibody to the circumsporozoite protein.
Similar articles
-
Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.Am J Trop Med Hyg. 1975 May;24(3):397-401. doi: 10.4269/ajtmh.1975.24.397. Am J Trop Med Hyg. 1975. PMID: 808142
-
The efficiency of sporozoite transmission in the human malarias, Plasmodium falciparum and P. vivax.Bull World Health Organ. 1987;65(3):375-80. Bull World Health Organ. 1987. PMID: 3311441 Free PMC article.
-
Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.Parassitologia. 1999 Sep;41(1-3):397-402. Parassitologia. 1999. PMID: 10697892 Review.
-
Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.J Infect Dis. 2002 Apr 15;185(8):1155-64. doi: 10.1086/339409. Epub 2002 Apr 1. J Infect Dis. 2002. PMID: 11930326
-
Malaria vaccine: a current perspective.J Vector Borne Dis. 2008 Mar;45(1):1-20. J Vector Borne Dis. 2008. PMID: 18399312 Review.
Cited by
-
Clustering and Erratic Movement Patterns of Syringe-Injected versus Mosquito-Inoculated Malaria Sporozoites Underlie Decreased Infectivity.mSphere. 2021 Apr 7;6(2):e00218-21. doi: 10.1128/mSphere.00218-21. mSphere. 2021. PMID: 33827910 Free PMC article.
-
Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.Infect Immun. 2004 Nov;72(11):6519-27. doi: 10.1128/IAI.72.11.6519-6527.2004. Infect Immun. 2004. PMID: 15501783 Free PMC article. Clinical Trial.
-
Experimental human challenge infections can accelerate clinical malaria vaccine development.Nat Rev Immunol. 2011 Jan;11(1):57-64. doi: 10.1038/nri2902. Nat Rev Immunol. 2011. PMID: 21179119 Review.
-
Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.PLoS One. 2016 Feb 17;11(2):e0148723. doi: 10.1371/journal.pone.0148723. eCollection 2016. PLoS One. 2016. PMID: 26886867 Free PMC article.
-
Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.PLoS Negl Trop Dis. 2016 Oct 19;10(10):e0005070. doi: 10.1371/journal.pntd.0005070. eCollection 2016 Oct. PLoS Negl Trop Dis. 2016. PMID: 27760143 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources